Merck KGaA said it expects earnings and sales for 2023 to be at the lower end of its outlook ranges, after reporting lower third-quarter revenue across all segments.
Merck KGaA said it expects earnings and sales for 2023 to be at the lower end of its outlook ranges, after reporting lower third-quarter revenue across all segments.